Research quality in the supplement space varies enormously — from rigorous RCTs with hundreds of participants to single-cell studies that have never been replicated in humans. This post examines the clinical evidence for Silica (Orthosilicic Acid) specifically, separating what the trials actually show from what manufacturers claim.
The evidence base: what we are working with
Key citations: See richResearch section for study filters and participant data. Evidence for Silica (Orthosilicic Acid) summarised from peer-reviewed clinical literature.
The clinical evidence for Silica (Orthosilicic Acid) is rated Grade B, meaning good clinical evidence from RCTs, some limitations.
How Silica (Orthosilicic Acid) produces its effects
Silicon is thought to act as a cross-linking agent in collagen and glycosaminoglycan matrices, improving the structural
Understanding the mechanism matters because it explains both the benefits and the limitations. Silica (Orthosilicic Acid) works through PINP — which is why the effects appear at the timescale they do, and why consistent dosing is more important than perfect timing.
What the numbers mean in practice
The improvement data above represents the average response seen across cited trials. A few important caveats:
Baseline matters. The larger the deficit from optimal, the larger the measurable improvement. Someone with severely depleted levels will see bigger changes than someone already in the optimal range.
Consistency matters more than dose. Missing doses regularly is more damaging to outcomes than taking a slightly lower dose consistently.
Individual variation is real. Some people are genetic non-responders to specific supplements. If you have tracked relevant markers and see no movement at 12 weeks on an adequate dose, the supplement may not be the right choice for your biochemistry.
Interpreting your own blood results
The markers most relevant to Silica (Orthosilicic Acid) are PINP. If you have a recent blood test, upload it to the SacredBod Analyzer to see where your levels sit and whether Silica (Orthosilicic Acid) is likely to be relevant for your specific results.
Summary of the evidence
Silica (Orthosilicic Acid) has a clinically meaningful effect on poor-bone-density in adults with relevant deficiency or suboptimal status. The evidence quality justifies its use as part of a targeted supplement protocol. It does not justify indefinite use without tracking outcomes or ignoring the safety profile outlined in the full guide.
Supplements mentioned

Silica (Orthosilicic Acid)
Minerals · 6–12 mg Si · 60 caps
People also ask
What does "Evidence Grade B" mean for Silica (Orthosilicic Acid)?
How long do the benefits of Silica (Orthosilicic Acid) last?
How do I track whether Silica (Orthosilicic Acid) is working for me?
Keep reading
Vanadyl Sulfate: what the research actually shows
A clinical evidence review of Vanadyl Sulfate — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Strontium Citrate: what the research actually shows
A clinical evidence review of Strontium Citrate — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Potassium Citrate: what the research actually shows
A clinical evidence review of Potassium Citrate — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.